The Significance of Intracellular Insulin to Insulin Action

Journal of Investigative Medicine

Volumn 45, Issue 2, 1997, Pages 20-27

  Duckworth, William C ^a,b   Bennett, Robert G ^a   Hamel, Frederick G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCAGON; INSULIN; INSULIN RECEPTOR; INSULINASE; SOMATOMEDIN B; SOMATOMEDIN C;

HUMAN; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SECOND MESSENGER;

CYCLIC AMP; GLUCAGON; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INSULYSIN; PHOSPHORYLATION; RECEPTOR, INSULIN; SECOND MESSENGER SYSTEMS;

EID: 0031062399     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Bygrave F, Benedetti A. Calcium: its modulation in liver by cross-talk between the actions of the glucagon and calcium-mobilizing agonists. Biochem J 1993;296:1-14.
2. Robles-Flores M, Allende G, Pina E, Garcia-Sainz JA. Cross-talk between glucagon- and adenosine-mediated signalling systems in rat hepatocytes: effects on cyclic AMP-phosphodiesterase activity. Biochem J 1995;312:763-7.
3. 2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase. J Biol Chem 1990;265:21514-9.
4. Blache P, Kervran A, Le-Nguyen D, Dufour M, Cohen-Sodal A, Duckworth W, Bataille D. Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon. J Biol Chem 1993;268:21748-53.
5. White MF, Stegmann EW, Dull TJ, Ullrich A, Kahn CR. Characterization of an endogenous substrate of the insulin receptor in cultured cells. J Biol Chem 1987;262:9769-77.
6. Wilden PA, Backer JM, Kahn CR, Cahill DA, Schroeder GJ, White MF. The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth. Proc Nat Acad Sci USA 1990;87:3358-62.
7. Thies RS, Ullrich A, McClain DA. Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem 1989;264:12820-5.
8. Goldfine ID. The insulin receptor: molecular biology and transmembrane signalling. Endocr Rev 1987;8:235.
9. Myers M, Grammer T, Wang L, Sun X, Blenis J, Pierce J. White M. IRS-1-dependent and -independent pathways in insulin signalling. Diabetes 1994;43:1A.
10. O'Brien R, Granner D. Regulation of gene expression by insulin. Biochem J 1991;278:609-19.
11. Pershadsingh HA, Gale RD, McDonald JM. Chelation of intracellular calcium prevents stimulation of glucose transport by insulin and insulinomimetic agents in the adipocyte. Evidence for a common mechanism. Endocrinology 1987;121:1727-32.
12. Solomon S, Palazzolo M, Elam M, Green S, Raghow R. Regulation of calmodulin gene expression by insulin is both transcriptional and post-transcriptional. J Lab Clin Med 1994;124:348-58.
13. Sacks DB, Fujita-Yamaguchi Y, Gale RD, McDonald JM. Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta. Biochem J 1989;263:803-12.
14. Williams JP, Jo H, Sacks DB, Crimmins DL, Thoma RS, Hunnicutt RE, Radding W, Sharma RK, McDonald JM. Tyrosine-phosphorylated calmodulin has reduced biological activity. Arch Biochem Biophys 1994;315:119-26.
15. Duckworth WC. Increasing understanding of calmodulin-insulin interactions, [editorial]. J Lab Clin Med 1994;124:311-2.
16. Sacks DB, Davis HW, Crimmins DL, McDonald JM. Insulin-stimulated phosphorylation of calmodulin. Biochem J 1992;286:211-6.
17. Duckworth WC. Insulin degradation: mechanisms, products, and significance. Endocr Rev 1988;9:319-45.
18. Backer JM, Kahn CR, White MF. The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells. J Biol Chem 1990;265:14828-35.
19. Hamel FG, Mahoney MJ, Duckworth WC. Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification. Diabetes 1991;40:436-43.
20. Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Amano K, Sakamoto T, Kawase Y, Akiyama H, Nagata M, Baba S. Insulin-degrading enzyme is capable of degrading receptor-bound insulin. Biochem Biophys Res Commun 1988;150:605-14.
21. Duckworth WC, Hamel FG, Liepnieks JJ, Peavy DE, Ryan MP, Hermodson MA, Frank BH. Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes. Biochem Biophys Res Commun 1987;147:615-21.
22. Duckworth WC, Hamel FG, Peavy DE, Liepnieks JJ, Ruan MP, Hermodson MA, Frank BH. Degradation products of insulin generated by hepatocytes and by insulin protease. J Biol Chem 1988;263:1826-33.
23. Hamel FG, Posner BI, Bergeron JJM, Frank BH, Duckworth WC. Isolation of insulin degradation products from endosomes derived from intact rat liver. J Biol Chem 1988;263:6703-8.
24. Becker AB, Roth RA. An unusual active site identified in a family of zinc metalloendopeptidases. Proc Natl Acad Sci USA 1992;89:3835-9.
25. Rawlings ND, Barrett AJ. Homologues of insulinase, a new superfamily of metalloendopeptidases. Biochem J 1991;275:389-91.
26. Shii K, Roth RA. Inhibition of insulin degradation by hepatoma cells after microinjections of monoclonal antibodies to a specific cytosolic protease. Proc Natl Acad Sci USA 1986;83:4147.
27. Authier F, Rachubinski R, Posner B, Bergeron J. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. J Biol Chem 1994;269:3010-6.
28. Steiner DF. Insulin today. Diabetes 1977;26:322-31.
29. Draznin B, Trowbridge M. Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: possible role of internalized hormone. J Biol Chem 1982;257(20):11988-93.
30. Peavy DE, Edmondson JW, Duckworth WC. Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes. Endocrinology 1984;114:753-60.
31. Hamel FG, Peavy DE, Ryan MP, Duckworth WC. High performance liquid chromatographic analysis of insulin degradation products from isolated hepatocytes: effects of inhibitors suggest intracellular and extracellular pathways. Diabetes 1987;36:702-8.
32. Hofmann CA, Lotan RM, Ku WW, Oeltmann TN. Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin. J Biol Chem 1983;258:11774-9.
33. Miller DS. Stimulation of RNA and protein synthesis by intracellular insulin. Science 1988;240:506-9.
34. Jochen AL, Berhanu P. Insulin-stimulated glucose transport and insulin internalization share a common postbinding step in adipocytes. Diabetes 1987;36:542-5.
35. Kayalar C, Wong WT. Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme. J Biol Chem 1989;264:8928-34.
36. Kayalar C, Wong WT, Hendrickson L. Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors. J Cell Biochem 1990;44:137-51.
37. Peavy D, Abram J, Frank B, Duckworth W. In vitro activity of biosynthetic human proinsulin: receptor binding and biological potency of proinsulin and insulin in isolated rat adipocytes. Diabetes 1984;33:1062-7.
38. Peavy DE, Brunner MR, Duckworth WC, Hooker CS, Frank BH. Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin: studies in cultured IM-9 lymphocytes and in vitro in rats. J Biol Chem 1985;260:13989-94.
39. Smith RM, Jarett L. Partial characterization of mechanism of insulin accumulation in H35 hepatoma cell nuclei. Diabetes 1990;39.683-9.
40. Soler AP, Thompson KA, Smith RM, Jarett L. Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells. Proc Natl Acad Sci USA 1989;86:6640-4.
41. Ding L, Becker AB, Akinori S, Roth RA. Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III. J Biol Chem 1992;267:2414-20.
42. Garcia JV, Fenton BW, Rosner MR. Isolation and characterization of an insulin-degrading enzyme from Drosophila melanogaster. Biochemistry 1988;27:4237-44.
43. Kole H, Smith D, Lenard J. Characterization and partial purification of an insulinase from neurospora crassa. Arch Biochem Biophys 1992;297:199-204.
44. Fujita A, Oka C, Arikawa Y, Katagal T, Tonouchi A, Kuhara S, Misumi Y. A yeast gene necessary for bud-site selection encodes a protein similar to insulin-degrading enzymes. Nature 1994;372:567-70.
45. Duckworth WC, Garcia JV, Liepnieks JJ, Hamel FG, Hermodson MA, Frank BH, Rosner MR. Drosophila insulin-degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites. Biochemistry 1989;28:2471-7.
46. Rawlings ND, Barrett AJ. Evolutionary families of peptidases. Biochem J 1993;290:205-18.
47. Hari J, Shii K, Roth RA. In vivo association of 1251 insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody. Endocrinology 1987;120:829-31.
48. Harada S, Smith R, Smith J, Jarett L. Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway. Endocrinology 1993;132:2293-8.
49. Bennett R, Hamel F, Duckworth W. Identification and isolation of a cytosolic proteolytic complex containing insulin-degrading enzyme and the multicatalytic proteinase. Biochem Biophys Res Commun 1994;202:1047-53.
50. Rivett AJ. Proteasomes: multicatalytic proteinase complexes. Biochem J 1993;291:1-10.
51. Barrett E, Jahn L, Oliveras E, Fryburg D. Chloroquine does not exert insulin-like actions on human forearm muscle metabolism. Am J Physiol 1995;268:E820-4.
52. Duckworth W, Bennett R, Hamel F. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J Biol Chem 1994;269:24575-80.
53. Bennett RG, Hamel FG, Duckworth WC. Characterization of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex. Diabetes 1997;46:197-203.
54. Kupfer SR, Marschke KB, Wilson EM, French FS. Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J Biol Chem 1993;268:17519-27.
55. Kupfer SR, Wilson EM, French FS. Androgen and glucocorticoid receptors interact with insulin-degrading enzyme. J Biol Chem 1994;269:20622-8.
56. Bennett RG, Hamel FG, Duckworth WC. Insulin inhibition of fatty acid α-oxidation in isolated peroxisomes. Diabetes 1996;45:310A.
57. Gehm BD, Rosner MR. Regulation of insulin, epidermal growth factor, and transforming growth factor-α levels by growth factor-degrading enzymes. Endocrinology 1991;128:1603-9.
58. Muller D, Baumeister H, Bucke F, Richter D. Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. Eur J Biochem 1991;202:285-92.
59. Roth RA, Mesirow ML, Yokono K, Baba S. Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. Endocr Res 1984;10(2):101-12.
60. Thompson K, Decker S, Rosner M. Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin. Proc Natl Acad Sci USA 1985;82:8443-7.
61. Stoppelli MP, Garcia JV, Decker SJ, Rosner MR. Developmental regulation of an insulin-degrading enzyme from Drosophila melanogaster. Proc Natl Acad Sci USA 1988;85:3469-73.
62. Kuo W, Montag A, Rosner M. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinology 1993;132:604-11.
63. Kuehn L, Dahlmann B, Kopp F. Effect of the multicatalytic proteinase (prosome) on translational activity in rabbit reticulocyte lysates. FEBS Lett 1990;261:274-8.
64. Draznin B. Insulin signaling network - waiting for Copernicus [editorial]. Endocrinology 1996;137:2647-8.